
|Articles|June 26, 2008
HIV drug Aptivus gains new indication approval for kids
Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.
Advertisement
Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The ‘Vacation Peptide’ Raises New Alarms Across Pharmacy
2
FDA Approves Garzulys as Third Biosimilar to NovoLog
3
Nonopioid Treatment Offers Safer, Effective Alternatives for Pain Management
4
Facing Reimbursement Pressure, Pharmacy Answers With Clinical Value
5

























